Utah Medical Products (UTMD) Net Margin (2010 - 2026)

Utah Medical Products' Net Margin history runs 17 years deep, the most recent figure standing at 29.86% for Q1 2026.

• In Q1 2026, Net Margin fell 146.0% year-over-year to 29.86%; the TTM figure through Mar 2026 stood at 22.75% (down 939.0% YoY), while the FY2025 annual figure was 23.3%, up 2274.0% from the prior year.
• Net Margin was 29.86% for Q1 2026 at Utah Medical Products, up from 2.81% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 35.61% in Q3 2024 to a low of 61.63% in Q4 2022.
• Historically, Net Margin has averaged 19.94% across 5 years, with a median of 30.62% in 2025.
• The sharpest annual moves came in 2022 and 2024: Net Margin plunged 9587 bps in 2022, then surged 7058 bps in 2024.
• A 5-year view of Net Margin shows it stood at 61.63% in 2022, then jumped by 31 bps to 42.6% in 2023, then surged by 166 bps to 27.98% in 2024, then plunged by 90 bps to 2.81% in 2025, then jumped by 963 bps to 29.86% in 2026.
• The last three Net Margin figures came in at 29.86% (Q1 2026), 2.81% (Q4 2025), and 26.81% (Q3 2025), per Business Quant data.